FDA Inspection 807158 — King Pharmaceuticals LLC

King Pharmaceuticals LLC — FEI 1876582

The FDA completed an inspection of King Pharmaceuticals LLC on December 13, 2012 in Rochester, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 13, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rochester, MI (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
121521 CFR 211.67(b)Written procedures not established/followed
430321 CFR 211.67(b)Written procedures fail to include
440221 CFR 211.192Written record of investigation incomplete